Sands BE, Schreiber S, Danese S, Kierkus J, et al. A Phase 2 Study of MORF-057, an Oral alpha4beta7 Integrin Inhibitor in Moderately to Severely Active Ulcerative Colitis. Clin Gastroenterol Hepatol 2025 Aug 4:S1542-3565(25)00648.
PMID: 40769468